Biocompatible Polymeric Nanoparticles as Promising Candidates for Drug Delivery

The use of polymeric nanoparticles (NPs) in pharmacology provides many benefits because this approach can increase the efficacy and selectivity of active compounds. However, development of new nanocarriers requires better understanding of the interactions between NPs and the immune system, allowing...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Langmuir : the ACS journal of surfaces and colloids. - 1992. - 31(2015), 23 vom: 16. Juni, Seite 6415-25
1. Verfasser: Łukasiewicz, Sylwia (VerfasserIn)
Weitere Verfasser: Szczepanowicz, Krzysztof, Błasiak, Ewa, Dziedzicka-Wasylewska, Marta
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2015
Zugriff auf das übergeordnete Werk:Langmuir : the ACS journal of surfaces and colloids
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Biocompatible Materials Drug Carriers Emulsifying Agents Dioctyl Sulfosuccinic Acid 10041-19-7 Polylysine 25104-18-1 Polyglutamic Acid mehr... 25513-46-6 Polyethylene Glycols 3WJQ0SDW1A
LEADER 01000naa a22002652 4500
001 NLM249372665
003 DE-627
005 20231224153432.0
007 cr uuu---uuuuu
008 231224s2015 xx |||||o 00| ||eng c
024 7 |a 10.1021/acs.langmuir.5b01226  |2 doi 
028 5 2 |a pubmed24n0831.xml 
035 |a (DE-627)NLM249372665 
035 |a (NLM)26013473 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Łukasiewicz, Sylwia  |e verfasserin  |4 aut 
245 1 0 |a Biocompatible Polymeric Nanoparticles as Promising Candidates for Drug Delivery 
264 1 |c 2015 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 14.03.2016 
500 |a Date Revised 02.12.2018 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a The use of polymeric nanoparticles (NPs) in pharmacology provides many benefits because this approach can increase the efficacy and selectivity of active compounds. However, development of new nanocarriers requires better understanding of the interactions between NPs and the immune system, allowing for the optimization of NP properties for effective drug delivery. Therefore, in the present study, we focused on the investigation of the interactions between biocompatible polymeric NPs and a murine macrophage cell line (RAW 264.7) and a human monocytic leukemia cell line (THP-1). NPs based on a liquid core with polyelectrolyte shells were prepared by sequential adsorption of polyelectrolytes (LbL) using AOT (docusate sodium salt) as the emulsifier and the biocompatible polyelectrolytes polyanion PGA (poly-l-glutamic acid sodium salt) and polycation PLL (poly l-lysine). The average size of the obtained NPs was 80 nm. Pegylated external layers were prepared using PGA-g-PEG (PGA grafted by PEG poly(ethylene glycol)). The influence of the physicochemical properties of the NPs (charge, size, surface modification) on viability, phagocytosis potential, and endocytosis was studied. Internalization of NPs was determined by flow cytometry and confocal microscopy. Moreover, we evaluated whether addition of PEG chains downregulates particle uptake by phagocytic cells. The presented results confirm that the obtained PEG-grafted NPs are promising candidates for drug delivery 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a Biocompatible Materials  |2 NLM 
650 7 |a Drug Carriers  |2 NLM 
650 7 |a Emulsifying Agents  |2 NLM 
650 7 |a Dioctyl Sulfosuccinic Acid  |2 NLM 
650 7 |a 10041-19-7  |2 NLM 
650 7 |a Polylysine  |2 NLM 
650 7 |a 25104-18-1  |2 NLM 
650 7 |a Polyglutamic Acid  |2 NLM 
650 7 |a 25513-46-6  |2 NLM 
650 7 |a Polyethylene Glycols  |2 NLM 
650 7 |a 3WJQ0SDW1A  |2 NLM 
700 1 |a Szczepanowicz, Krzysztof  |e verfasserin  |4 aut 
700 1 |a Błasiak, Ewa  |e verfasserin  |4 aut 
700 1 |a Dziedzicka-Wasylewska, Marta  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Langmuir : the ACS journal of surfaces and colloids  |d 1992  |g 31(2015), 23 vom: 16. Juni, Seite 6415-25  |w (DE-627)NLM098181009  |x 1520-5827  |7 nnns 
773 1 8 |g volume:31  |g year:2015  |g number:23  |g day:16  |g month:06  |g pages:6415-25 
856 4 0 |u http://dx.doi.org/10.1021/acs.langmuir.5b01226  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_22 
912 |a GBV_ILN_350 
912 |a GBV_ILN_721 
951 |a AR 
952 |d 31  |j 2015  |e 23  |b 16  |c 06  |h 6415-25